Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Front Endocrinol (Lausanne). 2021 Apr 15;12:656950. doi: 10.3389/fendo.2021.656950. eCollection 2021.
Acute symptomatic pituitary apoplexy is a rare and potentially life-threatening condition. However, pituitary apoplexy can also present with milder symptoms and stable hemodynamics. Due to the rarity of this inhomogeneous condition, clinical studies are important to increase the knowledge.
We retrospectively reviewed all consecutive cases of pituitary apoplexy being admitted between January 1, 2005 and December 31, 2019 at the Karolinska University Hospital, Stockholm, Sweden, for symptoms, results of magnetic resonance (MRI), biochemistry, management and mortality.
Thirty-three patients were identified with pituitary apoplexy, 18 were men (55%) and mean age was 46.5 (17.2) years. The incidence of symptomatic pituitary apoplexy was 1.6 patients/year (0.76 patients/1,000,000 inhabitants/year). The majority presented with headache (n=27, 82%) and hormonal deficiencies (n=18, 55%), which were most frequent in men. ACTH deficiency was present in nine patients (27% but 50% of those with hormonal deficiencies). All had the characteristic findings on MRI. Only three patients (9%) required acute pituitary surgery, while eight were operated after more than one week. Seven (21%) were on antithrombotic therapy. None of the patients died in the acute course. During follow-up (7.6 ± 4.3 years) none of the hormonal deficiencies regressed and 3 patients died from non-related causes.
Our study confirmed the rarity and the symptoms of this condition. Surprisingly, only 3 patients needed acute neurosurgical intervention, perhaps due to milder cases and a general intensified treatment of precipitating factors. An early awareness and in severe cases decision on pituitary surgery is of utmost importance to avoid severe complications.
急性症状性垂体卒中是一种罕见且可能危及生命的疾病。然而,垂体卒中也可能表现出较轻的症状和稳定的血流动力学。由于这种异质性疾病的罕见性,临床研究对于增加知识非常重要。
我们回顾性地审查了 2005 年 1 月 1 日至 2019 年 12 月 31 日期间在瑞典斯德哥尔摩卡罗林斯卡大学医院住院的所有连续垂体卒中病例,评估其症状、磁共振成像(MRI)结果、生物化学、治疗方法和死亡率。
共确定了 33 例垂体卒中患者,其中 18 例为男性(55%),平均年龄为 46.5(17.2)岁。有症状性垂体卒中的发病率为 1.6 例/年(0.76 例/100 万居民/年)。大多数患者表现为头痛(n=27,82%)和激素缺乏症(n=18,55%),男性更为常见。ACTH 缺乏症见于 9 例患者(27%,但 50%的激素缺乏症患者)。所有患者均有 MRI 的特征性表现。只有 3 例患者(9%)需要急性垂体手术,而 8 例患者在一周后才进行手术。7 例(21%)正在接受抗血栓治疗。在急性病程中无患者死亡。在随访期间(7.6±4.3 年),所有患者的激素缺乏症均未缓解,有 3 例患者死于非相关原因。
我们的研究证实了这种疾病的罕见性和症状。令人惊讶的是,只有 3 例患者需要急性神经外科干预,这可能是由于较轻的病例和对诱发因素的普遍强化治疗。早期意识到并在严重情况下决定进行垂体手术对于避免严重并发症至关重要。